OTUD5 inhibitors refer to a class of chemical compounds that have been investigated for their potential to modulate the activity of OTUD5 (OTU deubiquitinase 5), an enzyme belonging to the ovarian tumor (OTU) family of deubiquitinases. Deubiquitinases, including OTUD5, are critical regulators of the ubiquitin-proteasome system, a cellular pathway responsible for protein degradation and signaling. By targeting OTUD5, these inhibitors have the capacity to influence deubiquitination processes, impacting the stability and function of specific proteins. The exploration of OTUD5 inhibitors has emerged from the scientific interest in elucidating the role of deubiquitinases in cellular homeostasis and disease processes. Through their enzymatic activity, deubiquitinases like OTUD5 remove ubiquitin molecules from target proteins, influencing protein turnover and modifying cellular signaling pathways. By identifying specific inhibitors for OTUD5, researchers aim to investigate the functional consequences of inhibiting this particular deubiquitinase and better comprehend its role in cellular processes.
Chemically, OTUD5 inhibitors encompass a diverse array of compounds, each designed to interact with the enzyme's active site or allosteric regions. Researchers explore various chemical scaffolds and structural motifs to achieve selectivity and potency in inhibiting OTUD5 while minimizing potential off-target effects. The study of OTUD5 inhibitors is a dynamic area of research within the field of cellular biology. By characterizing these inhibitors and studying their effects on deubiquitination, researchers strive to gain insights into the specific mechanisms through which they modulate OTUD5 activity and regulate cellular processes. The identification of OTUD5 inhibitors could potentially serve as valuable tools for studying the functional consequences of deubiquitination on specific cellular pathways and protein networks. Importantly, it is essential to recognize that the current focus of studying OTUD5 inhibitors remains rooted in fundamental scientific inquiry and advancing our understanding of deubiquitinase-mediated cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $77.00 $188.00 $431.00 | 1 | |
A broad-spectrum deubiquitinase inhibitor that has been reported to target multiple deubiquitinases, including members of the OTU family. | ||||||
WP1130 | 856243-80-6 | sc-364650 sc-364650A | 10 mg 50 mg | $490.00 $1484.00 | 1 | |
Also known as degrasyn, this compound has been studied for its ability to inhibit deubiquitinases and induce apoptosis in cancer cells. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
A selective inhibitor of USP14, which is another deubiquitinase, but it may have off-target effects on other deubiquitinases like OTUD5. | ||||||
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $204.00 | 1 | |
A compound that targets the deubiquitinase USP7, but it may also have effects on other deubiquitinases. | ||||||
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | $119.00 $465.00 | ||
A small molecule that has been reported to inhibit the deubiquitinase USP8, but its effects on OTUD5 have not been extensively explored. | ||||||
P22077 | 1247819-59-5 | sc-478536 | 10 mg | $165.00 | ||
An inhibitor of the deubiquitinase USP7, but its effects on OTUD5 are not fully understood. | ||||||